10-Q: Aveanna Healthcare Reports Strong Q2 Growth

Aveanna Healthcare Holdings Inc. reported significant revenue and net income growth in Q2 2025, driven by strong performance across all segments and strategic acquisitions.

Summary

• Revenue increased by 16.8% to $589.6 million for the three-month period ended June 28, 2025, compared to $505.0 million in the prior year.
• Net income for the three-month period ended June 28, 2025, rose 94.3% to $27.0 million, up from $13.9 million in the comparable prior year period.
• Operating income for the three-month period ended June 28, 2025, surged 115.6% to $80.0 million, compared to $37.1 million in the prior year.
• Gross margin percentage improved to 35.8% in the three-month period ended June 28, 2025, up from 31.3% in the prior year.
• Acquired Thrive Skilled Pediatric Care, LLC on June 2, 2025, for approximately $75.7 million, including the issuance of 11.2 million shares of common stock.
• Net cash provided by operating activities for the six-month period ended June 28, 2025, was $42.9 million, a significant improvement from a $10.2 million use of cash in the prior year.
• Successfully settled a $7.9 million arbitration award, resulting in a $6.2 million net reduction to Cost of Revenue for the three and six-month periods ended June 28, 2025.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial performance with significant increases in revenue, net income, and operating income, coupled with improved margins and positive cash flow from operations. The strategic acquisition of Thrive expands its market reach. While regulatory changes pose future risks, the current results indicate effective operational management and growth.

Positives

• Strong revenue growth across all segments: Private Duty Services (PDS) revenue increased by 19.2%, Home Health & Hospice (HHH) revenue by 10.0%, and Medical Solutions (MS) revenue by 2.2% in Q2 2025.
• Significant increases in net income (94.3%) and operating income (115.6%) for the three-month period ended June 28, 2025.
• Improved gross margin percentages across all segments, indicating better cost management and reimbursement optimization.
• Positive shift in cash flow from operations, providing $42.9 million for the first six months of 2025 compared to a cash outflow in the prior year.
• Successful acquisition of Thrive Skilled Pediatric Care, LLC, expanding geographic footprint and service offerings into two new states.
• Reduction in interest expense by $3.6 million in Q2 2025, driven by a lower principal balance on the 2021 Extended Term Loan and decreases in the U.S. federal funds rate.
• Successful resolution of a $7.9 million arbitration award, leading to a $6.2 million reduction in Cost of Revenue.
• Days Sales Outstanding (DSO) slightly improved to 47.2 days as of June 28, 2025, from 47.8 days as of June 29, 2024.
• Securitization Facility maximum amount increased from $225.0 million to $275.0 million, enhancing liquidity.
• Revolving Credit Facility maturity extended to April 15, 2028, providing longer-term financing flexibility.

Negatives

• Income tax expense increased significantly to $17.1 million in Q2 2025 from a $9.9 million benefit in Q2 2024.
• Other (expense) income shifted from a $6.4 million income in Q2 2024 to a $0.0 million expense in Q2 2025, primarily due to non-cash valuation losses on interest rate derivatives and decreased net settlements.
• Acquisition-related costs of $3.4 million were incurred in Q2 2025 associated with the Thrive acquisition.
• Corporate expenses increased by 14.2% in Q2 2025, partly due to severance and additional compensation and benefits costs necessary to support the integration of the Thrive acquisition and increased professional services expenses related to legal matters.
• The Centers for Medicare & Medicaid Services (CMS) proposed rule for calendar year 2026 home health prospective payment system estimates a 6.4% reduction in home health payments, which could negatively affect the Home Health & Hospice segment.
• The 'One Big Beautiful Bill Act' (OBBBA), enacted on July 4, 2025, projects a $1.15 trillion reduction to federal Medicaid spending over the next 10 years, which may indirectly impact future rate expansion for certain Medicaid-funded services.
• The Medical Solutions segment experienced a 3.2% decline in volume for the three-month period ended June 28, 2025, partially offset by an increase in revenue rate.

Risks

• Intense competition among home health, hospice, and durable medical equipment companies.
• Ability to maintain relationships with existing patient referral sources.
• Ability to have services funded from third-party payers, including Medicare, Medicaid, and private health insurance companies, particularly due to changes under the 'One Big Beautiful Bill Act'.
• Changes to Medicare or Medicaid rates or methods governing payments, and the implementation of alternative payment models, including Medicare Advantage and managed care.
• Downward pressure on reimbursement resulting from further proliferation of Medicare Advantage plans.
• Limited ability to control reimbursement rates received for services.
• Delays in collection or non-collection of patient accounts receivable, especially during business integration or system transitions.
• Healthcare reform and other regulations, including risks related to the proposed rule issued for the home health prospective payment system by Centers for Medicare & Medicaid Services.
• Changes in the case-mix of patients, as well as payer mix and payment methodologies.
• Any reduction in net reimbursement if value-based care programs are not effectively implemented.
• Material adverse effects on business, financial condition, and results of operations from public health emergencies, such as a pandemic or other infectious disease outbreak.
• Challenges in the acquisition and integration of acquired businesses or assets.
• Shortages in qualified employees and management, and competition for qualified personnel.
• Any failure to maintain the security and functionality of information systems or to defend against or otherwise prevent a cybersecurity attack or breach.
• Substantial indebtedness, which increases vulnerability to general adverse economic and industry conditions and may limit the ability to pursue strategic alternatives and react to changes in business and industry.
• Ability to identify, acquire, successfully integrate, and obtain financing for strategic and accretive acquisitions.
• Risks related to legal proceedings, claims, and governmental inquiries, given that the nature of the business exposes the company to various liability claims which may exceed the level of insurance coverage.
• Uncertainty regarding the timing or outcome of the U.S. Department of Justice, Antitrust Division, investigation into nurse wages, reimbursement rates, and hiring activities.
• Uncertainty regarding the timing or outcome of the Civil Investigation Demand from the U.S. Department of Justice regarding Comfort Care Hospice, LLC, concerning improper claims and remuneration for referrals.

Future Outlook

The company is evaluating the full effects of the recently enacted 'One Big Beautiful Bill Act' on its estimated annual effective tax rate and cash tax position, noting that most provisions are effective from December 31, 2026, or later. While no direct impact on Medicaid waiver programs or reimbursement rates is expected, the resulting reductions to state Medicaid budgets may indirectly affect future rate expansion for certain Medicaid-funded services. The Centers for Medicare & Medicaid Services (CMS) proposed rule for calendar year 2026 home health prospective payment system estimates a 6.4% reduction in home health payments, which could negatively affect the Home Health & Hospice segment.

Management Comments

• Our platform creates sustainable competitive advantages that support our ability to continue driving rapid growth, both organically and through acquisitions, and positions us as the partner of choice for the patients we serve.
• Management believes that a loss event is not probable and that this matter will not materially impact the Company’s business, results of operations or financial condition regarding the ongoing DOJ investigations.
• Our operating cash flows, available cash on hand, and availability under our Securitization Facility and Revolving Credit Facility will be sufficient to meet our cash requirements for at least the next twelve months.

Industry Context

The company operates in the highly competitive and rapidly evolving U.S. home healthcare industry, providing a lower-cost alternative to hospitalization for medically complex patients. The industry faces significant regulatory changes, including potential reductions in Medicare and Medicaid reimbursement rates as proposed by CMS and the broader federal Medicaid spending cuts outlined in the 'One Big Beautiful Bill Act'. These changes could pressure margins, particularly in the Home Health & Hospice segment. The company's strategic acquisition of Thrive Skilled Pediatric Care aligns with an industry trend of consolidation and expansion to achieve greater market density and service diversification, aiming to leverage scale to navigate reimbursement pressures and labor shortages.

Comparison to Industry Standards

• The company's focus on 'medically complex, high-cost patient populations' and providing 'safe, high-quality care in the home' aligns with broader healthcare trends emphasizing value-based care and shifting services from institutional settings to lower-cost home environments.
• The acquisition of Thrive Skilled Pediatric Care, expanding into new states and increasing market density, is a common strategy in the fragmented home healthcare market to achieve economies of scale and improve competitive positioning.
• The reported gross margin percentage improvements (e.g., PDS up 5.3% to 32.5%, HHH up 1.2% to 55.0%) suggest effective management of labor and product costs, which is critical in a sector facing rising caregiver wages and reimbursement pressures.
• The company's substantial indebtedness and reliance on variable interest rate debt are common characteristics for healthcare providers that grow through acquisition, but also expose them to interest rate fluctuations, as evidenced by the valuation losses on interest rate derivatives.
• The regulatory risks, particularly the proposed CMS payment reductions for home health and the broader Medicaid spending cuts, are industry-wide challenges that all home healthcare providers must navigate, potentially impacting future revenue growth and profitability.

Corporate Governance

Legal Proceedings

• A $7.9 million arbitration award against the company related to a Texas non-subscriber benefit plan claim was settled in May 2025, resulting in a $6.2 million reduction to Cost of Revenue.
• Ongoing grand jury subpoenas issued by the U.S. Department of Justice, Antitrust Division, since October 30, 2019, requiring production of documents and information pertaining to nurse wages, reimbursement rates, and hiring activities in a few local markets. Management believes a loss event is not probable.
• Ongoing Civil Investigation Demand issued by the U.S. Department of Justice, Middle District of Alabama, since July 19, 2023, regarding Comfort Care Hospice, LLC, concerning issues of improper submission of claims to Medicare and other federal healthcare programs and improper remuneration for patient referrals. Management believes a loss event is not probable.

Related Party Transactions

• One of the company's significant shareholders owned 9.2% of the 2021 Extended Term Loan as of June 28, 2025.

Stakeholder Impact

• Shareholders: Positive impact from increased net income, operating income, and improved cash flow. Potential dilution from shares issued for the Thrive acquisition. Officers' 10b5-1 plans for sell-to-cover transactions could lead to minor market sales.
• Employees: Higher caregiver labor costs noted. Incentive compensation expense increased due to improved forecasted performance. Senior Management Retention Plan awards vested, accelerating compensation.
• Patients: Expansion of services through the Thrive acquisition, offering broader pediatric home care.
• Payers (Medicare/Medicaid): Potential future reductions in reimbursement rates due to proposed CMS rules and the 'One Big Beautiful Bill Act' could impact the company's revenue from these sources.

Next Steps

• Evaluate the full effects of the 'One Big Beautiful Bill Act' on estimated annual effective tax rate and cash tax position.
• Monitor the final rule from CMS regarding the calendar year 2026 home health prospective payment system, with the comment period ending August 29, 2025.
• Continue integrating Thrive Skilled Pediatric Care, LLC into operations and financial controls.
• Manage potential indirect impacts of Medicaid budget reductions on future rate expansion.
• Officers will proceed with 'sell-to-cover' transactions for tax withholding obligations related to RSU vesting.

Key Dates

Recommendation

While the company demonstrated strong financial performance with significant revenue and profit growth, and a strategic acquisition, the positive outlook is tempered by notable regulatory headwinds. The proposed CMS payment reductions for home health and the broader Medicaid spending cuts from the 'One Big Beautiful Bill Act' introduce significant uncertainty and potential future pressure on reimbursement rates and margins. The company's substantial indebtedness also remains a factor. Given the strong operational improvements balanced against these significant future regulatory risks, a 'hold' recommendation is appropriate, advising investors to monitor the impact of the regulatory changes closely before making further investment decisions.

Keywords

Healthcare, Home Health, Hospice, Pediatric Care, Medical Solutions, SEC Filing, 10-Q, Financial Results, Acquisition, Thrive Skilled Pediatric Care, Medicaid, Medicare, Reimbursement Rates, Patient Care, Nursing Services, Financial Performance, AVAH